An Observational Study of Patients With Metabolic Syndrome and Related Conditions
Condition:   Metabolic Syndrome Intervention:   Sponsor:   Target PharmaSolutions, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials

A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome
Conditions:   Essential Hypertension;   Metabolic Syndrome Interventions:   Drug: Telmisartan;   Drug: Losartan Sponsor:   Chong Kun Dang Pharmaceutical Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials

An Observational Study of Patients With Metabolic Syndrome and Related Conditions
Condition:   Metabolic Syndrome Intervention:   Sponsor:   Target PharmaSolutions, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials

A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome
Conditions:   Essential Hypertension;   Metabolic Syndrome Interventions:   Drug: Telmisartan;   Drug: Losartan Sponsor:   Chong Kun Dang Pharmaceutical Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 4, 2023 Category: Research Source Type: clinical trials

An Observational Study of Patients With Metabolic Syndrome and Related Conditions
Condition:   Metabolic Syndrome Intervention:   Sponsor:   Target PharmaSolutions, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 4, 2023 Category: Research Source Type: clinical trials

A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome
Conditions:   Essential Hypertension;   Metabolic Syndrome Interventions:   Drug: Telmisartan;   Drug: Losartan Sponsor:   Chong Kun Dang Pharmaceutical Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 4, 2023 Category: Research Source Type: clinical trials

An Observational Study of Patients With Metabolic Syndrome and Related Conditions
Condition:   Metabolic Syndrome Intervention:   Sponsor:   Target PharmaSolutions, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 4, 2023 Category: Research Source Type: clinical trials

A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome
Conditions:   Essential Hypertension;   Metabolic Syndrome Interventions:   Drug: Telmisartan;   Drug: Losartan Sponsor:   Chong Kun Dang Pharmaceutical Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 4, 2023 Category: Research Source Type: clinical trials

An Observational Study of Patients With Metabolic Syndrome and Related Conditions
Condition:   Metabolic Syndrome Intervention:   Sponsor:   Target PharmaSolutions, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 4, 2023 Category: Research Source Type: clinical trials

The Effect of Feedback on Physical Activity Surveillance Using Wearable Device-Smartphone Application for Resolution of Metabolic Syndrome in Aged 60 or Older
Conditions:   Metabolic Syndrome;   Physical Activity;   Wearable Device Interventions:   Other: Receving feedback;   Other: No regular feedback Sponsor:   Pusan National University Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2023 Category: Research Source Type: clinical trials